Big Pharma Is Going Holiday Shopping. Who's Next?

Big Pharma Is Going Holiday Shopping. Who's Next?

Source: 
Motley Fool
snippet: 
  • ChemoCentryx has a treatment that targets inflammation without immune-system suppression.
  • Epizyme has multiple trials in the works for its already approved novel cancer treatment.
  • Magenta Therapeutics may make stem cell transplants easier and expand the market in the process.